S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Nevada Could be the Source for America's Green Future (Ad)
3 Undervalued Dividend Payers For Volatile Market Conditions
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Lithium Could Be 2023's Next Big Surprise (Ad)
Roku And The 20% Rally That’s About To Start 
3 More Downgrades To Put On Your Buy List 
Lithium Could Be 2023's Next Big Surprise (Ad)
The Bottom Is In For McCormick & Company
Buffett's company owns nearly 24% of Occidental Petroleum
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Nevada Could be the Source for America's Green Future (Ad)
3 Undervalued Dividend Payers For Volatile Market Conditions
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Lithium Could Be 2023's Next Big Surprise (Ad)
Roku And The 20% Rally That’s About To Start 
3 More Downgrades To Put On Your Buy List 
Lithium Could Be 2023's Next Big Surprise (Ad)
The Bottom Is In For McCormick & Company
Buffett's company owns nearly 24% of Occidental Petroleum
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Nevada Could be the Source for America's Green Future (Ad)
3 Undervalued Dividend Payers For Volatile Market Conditions
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Lithium Could Be 2023's Next Big Surprise (Ad)
Roku And The 20% Rally That’s About To Start 
3 More Downgrades To Put On Your Buy List 
Lithium Could Be 2023's Next Big Surprise (Ad)
The Bottom Is In For McCormick & Company
Buffett's company owns nearly 24% of Occidental Petroleum
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Nevada Could be the Source for America's Green Future (Ad)
3 Undervalued Dividend Payers For Volatile Market Conditions
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Lithium Could Be 2023's Next Big Surprise (Ad)
Roku And The 20% Rally That’s About To Start 
3 More Downgrades To Put On Your Buy List 
Lithium Could Be 2023's Next Big Surprise (Ad)
The Bottom Is In For McCormick & Company
Buffett's company owns nearly 24% of Occidental Petroleum
NASDAQ:OBSV

ObsEva - OBSV Stock Forecast, Price & News

$0.08
-0.02 (-20.00%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.07
$0.09
50-Day Range
$0.08
$0.23
52-Week Range
$0.08
$2.14
Volume
754,578 shs
Average Volume
8.94 million shs
Market Capitalization
$6.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.40

ObsEva MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
9,275.0% Upside
$7.50 Price Target
Short Interest
Healthy
1.73% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.93mentions of ObsEva in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.97 out of 5 stars


OBSV stock logo

About ObsEva (NASDAQ:OBSV) Stock

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.

Receive OBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ObsEva and its competitors with MarketBeat's FREE daily newsletter.

OBSV Stock News Headlines

StockNews.com Begins Coverage on ObsEva (NASDAQ:OBSV)
Lithium Could Be 2023's Next Big Surprise
Lithium is the hottest commodity for our green future
ObsEva (NASDAQ:OBSV) Coverage Initiated at StockNews.com
Nevada Could be the Source for America's Green Future
Industry shift towards lithium driven by green energy goals
Why Is ObsEva (OBSV) Stock Up 93% Today?
Why ObsEva (OBSV) Stock Is Down 36% Today
ObsEva Announces Dismissal of Moratorium Proceedings
ObsEva SA (OBSV) Reports Q3 Loss, Lags Revenue Estimates
ObsEva SA (OBSV)
See More Headlines
Receive OBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ObsEva and its competitors with MarketBeat's FREE daily newsletter.

OBSV Company Calendar

Last Earnings
11/04/2021
Today
3/29/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:OBSV
Fax
N/A
Employees
48
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.50
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$1.00
Forecasted Upside/Downside
+10,400.0%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
4 Analysts

Profitability

Net Income
$-58,380,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20.11 million
Book Value
$0.41 per share

Miscellaneous

Free Float
66,743,000
Market Cap
$6.24 million
Optionable
Not Optionable
Beta
0.68

Key Executives

  • William M. Brown
    Chief Executive & Financial Officer
  • Elke Bestel
    VP, Head-Drug Safety & Pharmacovigilance
  • Katja Buhrer
    Chief Strategy Officer













OBSV Stock - Frequently Asked Questions

Should I buy or sell ObsEva stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ObsEva in the last year. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" OBSV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OBSV, but not buy additional shares or sell existing shares.
View OBSV analyst ratings
or view top-rated stocks.

What is ObsEva's stock price forecast for 2023?

4 Wall Street analysts have issued 12-month price targets for ObsEva's stock. Their OBSV share price forecasts range from $1.00 to $12.00. On average, they anticipate the company's share price to reach $7.50 in the next twelve months. This suggests a possible upside of 9,275.0% from the stock's current price.
View analysts price targets for OBSV
or view top-rated stocks among Wall Street analysts.

How have OBSV shares performed in 2023?

ObsEva's stock was trading at $0.1450 at the start of the year. Since then, OBSV stock has decreased by 44.8% and is now trading at $0.08.
View the best growth stocks for 2023 here
.

How were ObsEva's earnings last quarter?

ObsEva SA (NASDAQ:OBSV) released its quarterly earnings results on Thursday, November, 4th. The company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.22) by $0.23.

What other stocks do shareholders of ObsEva own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ObsEva investors own include Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), Dynavax Technologies (DVAX), Matinas BioPharma (MTNB), Trevena (TRVN), Zosano Pharma (ZSAN), Vaxart (VXRT), VBI Vaccines (VBIV), Bionano Genomics (BNGO) and ADMA Biologics (ADMA).

When did ObsEva IPO?

(OBSV) raised $98 million in an initial public offering on Thursday, January 26th 2017. The company issued 6,500,000 shares at $14.00-$16.00 per share. Credit Suisse, Jefferies and Leerink Partners acted as the underwriters for the IPO.

What is ObsEva's stock symbol?

ObsEva trades on the NASDAQ under the ticker symbol "OBSV."

Who are ObsEva's major shareholders?

ObsEva's stock is owned by many different retail and institutional investors. Top institutional investors include Credit Suisse AG (2.25%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of ObsEva?

Shares of OBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ObsEva's stock price today?

One share of OBSV stock can currently be purchased for approximately $0.08.

How much money does ObsEva make?

ObsEva (NASDAQ:OBSV) has a market capitalization of $6.24 million and generates $20.11 million in revenue each year. The company earns $-58,380,000.00 in net income (profit) each year or ($0.92) on an earnings per share basis.

How can I contact ObsEva?

ObsEva's mailing address is Chemin des Aulx 12 Plan-les-Ouates, Geneva V8, 1228. The official website for the company is www.obseva.com. The company can be reached via phone at (122) 552-3840 or via email at ir@obseva.ch.

This page (NASDAQ:OBSV) was last updated on 3/29/2023 by MarketBeat.com Staff